The Anaplasma - Ehrlichia, Antibodies IgG test is a serological assay used to diagnose ehrlichiosis and anaplasmosis.
Anaplasma and Ehrlichia are two distinct genera of bacteria that can cause similar tick-borne infections in humans.
This test can detect the Antibodies IgG against both species, but without separating them.
The Anaplasma-Ehrlichia Antibodies IgG test is essential for clinical diagnosis and public health surveillance, providing insights into individual patient care and broader disease control efforts.
IgG antibodies indicate past exposure or ongoing immune response to an infection, and they typically develop later in the infection cycle. Testing for IgG antibodies provides valuable information in diagnosing and epidemiological tracking these tick-borne diseases.
These diseases are transmitted through tick bites, with Anaplasma phagocytophilum and Ehrlichia chaffeensis being the most common pathogens. They can cause symptoms like fever, headache, and muscle aches and, in severe cases, lead to more serious health issues such as organ failure or severe respiratory symptoms. Typically, antibiotics such as doxycycline are used to treat active infections.
